Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$49.57 - $72.63 $500,657 - $733,563
-10,100 Reduced 71.63%
4,000 $285,000
Q3 2023

Nov 14, 2023

BUY
$58.86 - $72.67 $829,926 - $1.02 Million
14,100 New
14,100 $844,000
Q2 2022

Aug 08, 2022

SELL
$74.52 - $117.06 $89,424 - $140,472
-1,200 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$94.99 - $151.56 $446,453 - $712,332
-4,700 Reduced 79.66%
1,200 $135,000
Q4 2021

Feb 14, 2022

BUY
$127.69 - $165.85 $306,456 - $398,040
2,400 Added 68.57%
5,900 $911,000
Q3 2021

Nov 15, 2021

BUY
$102.33 - $144.73 $358,155 - $506,554
3,500 New
3,500 $488,000
Q2 2021

Aug 16, 2021

SELL
$113.03 - $155.64 $666,877 - $918,275
-5,900 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$99.52 - $215.83 $587,168 - $1.27 Million
5,900 New
5,900 $899,000
Q3 2020

Nov 16, 2020

SELL
$89.56 - $126.72 $143,296 - $202,752
-1,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$68.28 - $123.65 $109,248 - $197,840
1,600 New
1,600 $179,000
Q1 2020

May 15, 2020

SELL
$63.37 - $107.88 $1.03 Million - $1.75 Million
-16,200 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$96.94 - $113.59 $601,028 - $704,258
6,200 Added 62.0%
16,200 $1.69 Million
Q3 2019

Nov 14, 2019

SELL
$86.25 - $120.16 $1.31 Million - $1.83 Million
-15,200 Reduced 60.32%
10,000 $995,000
Q2 2019

Aug 14, 2019

BUY
$107.38 - $129.34 $2.52 Million - $3.04 Million
23,500 Added 1382.35%
25,200 $2.88 Million
Q1 2019

May 15, 2019

BUY
$105.93 - $142.47 $52,965 - $71,235
500 Added 41.67%
1,700 $214,000
Q4 2018

Feb 14, 2019

SELL
$128.36 - $272.13 $872,848 - $1.85 Million
-6,800 Reduced 85.0%
1,200 $163,000
Q3 2018

Nov 14, 2018

SELL
$211.18 - $274.49 $211,180 - $274,490
-1,000 Reduced 11.11%
8,000 $2.2 Million
Q2 2018

Aug 14, 2018

BUY
$150.77 - $207.98 $1.36 Million - $1.87 Million
9,000 New
9,000 $1.87 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.98B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.